BFRGW — BullFrog AI Holdings, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1829247 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | 0 | -1,614,627 | -1,593,161 | 5,538,863 | 5,080,463 | 652,072 |
| Dec 2025 | 0 | 0 | -1,498,660 | -1,480,174 | 2,808,351 | 2,183,705 | 672,022 |
| Sep 2025 | 83,413 | 15,370 | -1,569,683 | -1,551,612 | 2,702,356 | 1,990,712 | 758,701 |
| Jun 2025 | 33,257 | 6,522 | -1,469,673 | -1,448,729 | 2,869,194 | 2,473,635 | 681,084 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,418,228
Investing CF
$0
Financing CF
$6,801,763
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-24,884,785
Inventory
—
Receivables
$58,335
ST Investments
—
EBIT TTM
$-6,068,080
Pretax Income TTM
$-6,073,676
Interest Exp TTM
$5,596
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 116,670 | -6,594,636 | -6,498,068 | 2,808,351 | 672,022 | — | -5,522,265 |
| Dec 2024 | 0 | -7,236,383 | -6,993,647 | 5,551,830 | 588,090 | — | -5,610,249 |
| Dec 2023 | 65,000 | -5,367,524 | -5,355,869 | 2,776,586 | 184,350 | — | -6,001,299 |
| Dec 2022 | 10,000 | -2,455,801 | -2,802,487 | 80,369 | 3,137,721 | — | -910,890 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $991.62B | $1112.00 | — |
| JNJ | JOHNSON & JOHNSON | $563.77B | $234.20 | — |
| ABBV | AbbVie Inc. | $390.87B | $221.23 | — |
| NVS | NOVARTIS AG | $287.89B | $150.88 | — |
| MRK | Merck & Co., Inc. | $285.12B | $115.44 | — |
News headlines (Yahoo Finance, 1h cache)
BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
2026-06-02 12:00 · Yahoo
BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
2026-04-22 11:30 · Yahoo
RedChip's Biotech Investor Conference Replays Now Available
2026-04-20 12:00 · Yahoo
BullFrog AI Announces Participation at AACR Annual Meeting
2026-04-14 11:30 · Yahoo
BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
2026-04-13 11:30 · Yahoo
RedChip Showcases Public Companies Driving Biotech Innovation at April 16 Virtual Investor Conference
2026-04-02 12:45 · Yahoo
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
2026-03-30 11:30 · Yahoo
RedChip AI Investor Conference Replays Now Available Featuring Public Companies Across the Artificial Intelligence Value Chain
2026-03-26 13:00 · Yahoo
BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
2026-03-25 12:00 · Yahoo
RedChip's March 19 AI Investor Conference to Spotlight Public Companies Developing Real-World AI Applications and Infrastructure
2026-03-17 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.